NutriSupLaw articles

Joel B. Rothman interviewed by Nutraceuticals World

Joel B. Rothman interviewed by Nutraceuticals World

Arnstein & Lehr West Palm Beach Partner Joel B. Rothman was interviewed by Nutraceuticals World magazine in their July 6 issue. In the article, titled “Interview with Joel Rothman,” Mr. Rothman is asked about several work and personal matters, including our firm’s core values, his thoughts on the supplement industry, and his favorite part of […]

Joel Rothman speaks at Northwestern on intellectual property and advertising law

Schneider Rothman IP Law Group partner Joel B. Rothman was a guest lecturer on April 12 at Northwestern University’s Medill School of Journalism, Media and Integrated Marketing Communications masters degree program. Mr. Rothman spoke to two sections of a graduate class entitled “Law, Policy & Media” and addressed topics on advertising law, claim substantiation, unfair/deceptive practices, and intellectual

Class Action Lawsuits and Dietary Supplements: Not Always a Fit?

I have an article published in this month’s Nutritional Outlook that discusses our recent big win for energy drink maker Celsius in a class action filed against it in California state court. My article discusses class actions challenging advertising and labeling claims for dietary supplements and food products in which companies are accused of making

A Brief Survey of the Food Safety Modernization Act

Editor’s Note: This article is written by contributing writer Shafiel A. Karim Earlier this year, President Obama signed the Food Safety Modernization Act (FMSA), which amends various portions of the United States Code relating to FDA’s powers to detain and regulate domestic and imported food products.  While the law was primarily drafted to grant the

Dietary Supplement Firms, CGMPs and the Park Doctrine

Editor’s Note: This article is written by Contributing Writer Shafiel A. Karim. As FDA continues to inspect dietary supplement manufacturers under the new CGMP framework, it is clear that many manufacturers share similar deficiencies.  Recent FDA warning letters show that many manufacturers are still struggling with structure function claims, the required pre- and post-production qualitative

Irwin Naturals Announces California Settlement of Investigation into Mislabeling and False Advertising

Below is a press release issued by Irwin Naturals about its settlement of an investigation into its mislabeling and falsely advertising some of its products under California Law: Irwin Naturals, one of the nation’s leading suppliers of natural dietary and herbal supplements, announces that it has reached a settlement with a California task force that

FDA Commissioner Attempts to Curb Regulated Drug Use in Nutritional Supplements

With an ongoing rise in nutritional supplements containing chemicals regulated as drugs, the Commissioner of the Food and Drug Administration recently sent a letter to all manufacturers of dietary supplements reminding them of their concern of this matter and their plans to reduce the problem. The purpose of the letter is stated as to “address